Clinical trial opportunities,
matched by screening.
Study availability changes. Contact Delta Clinical Research to ask about current and upcoming protocols, eligibility, visit requirements, and participant compensation.
Current Availability
Why we screen before listing details.
Clinical trial eligibility depends on the exact protocol, medical history, medications, lab values, and visit schedule. Delta confirms those details directly with each participant before enrollment.
We do not publish placeholder NCT numbers, sponsor names, or compensation ranges. When a study is a possible match, the coordinator reviews the study-specific informed consent information with you.
- Step 01
Contact the site
Call or send the contact form so a coordinator can understand what kind of study you are looking for.
- Step 02
Complete pre-screening
The team reviews basic health details and current protocol availability before scheduling any visit.
- Step 03
Review informed consent
If a study may fit, you receive the study-specific risks, procedures, visit schedule, and compensation details before deciding.
- Step 04
Participate voluntarily
Enrollment is always optional, and you may withdraw from a study at any time.
Areas of Interest
Common study categories
These categories describe research areas Delta can evaluate. They do not mean every category has an actively enrolling study today.
CNS & Neurology
Migraine · Memory concerns · Mood disorders · Sleep disorders · Peripheral nerve symptoms
Metabolic & Endocrine
Diabetes · Obesity · Thyroid conditions · Hormone-related conditions · Cardiometabolic risk
Cardiovascular
Hypertension · Heart failure · Lipid disorders · Cardiovascular risk · Circulation concerns
Ophthalmology
Dry eye · Retinal conditions · Eye inflammation · Vision symptoms · Ocular surface disease
General Medicine
Respiratory infections · Vaccines · Pain · Preventive care · Common chronic conditions
Next Step
Ask about current study availability
A coordinator can help determine whether there is a current or upcoming protocol worth screening for.